FIELD: chemistry.
SUBSTANCE: invention relates to biotechnology and specifically methods of forecasting development of cancer and can be used in medicine. The method of performing forecast for a patient suffering from NSCLC involves determining the expression level of ChoK beta or ChoK beta and ChoK alpha in a sample collected from said patient. Low levels of ChoK beta relative to the levels in a standard sample indicate a bad forecast for the patient. Low levels of ChoK alpha and high levels of ChoK beta relative to the expression levels of said proteins in the standard sample indicate a good forecast for the patient.
EFFECT: invention enables to forecast probability of survival, for example, survival without relapses for a patient with NSCLC.
6 cl, 16 dwg, 2 tbl, 3 ex
